Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

Completed

• Conditions: Polycystic Ovary Syndrome

• Registration Number: NCT01350895
• Lead Sponsor: Taipei Medical University WanFang Hospital

Brief Summary

To study the clinical and biochemical characteristics women with polycystic ovary syndrome (PCOS) in different aged groups.

Detailed Description

Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive age women, affecting an estimated 9-18% of all women in this age group. To diagnose of PCOS in early life is especially important because it is now thought to increase metabolic and cardiovascular risks. Investigating PCOS is crucial as it is now considered to increase metabolic and cardiovascular risk, thereby impacting the health of women to a much greater extent than previously thought. We are plan using retrospective analysis to evaluate the clinical and biochemical presentation of PCOS in different aged groups.

Study Timeline

• Study Start: 2011-02
• Study First Submitted: 2011-05-09
• Study First Submitted QC: 2011-05-09
• Study First Posted: 2011-05-10
• Primary Completion: 2012-04
• Study Completion: 2012-04
• Status Verified: 2013-11
• Last Update Submitted: 2013-11-04
• Last Update Posted: 2013-11-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 781

Inclusion Criteria

• Reproductive age women with sufficient data

Exclusion Criteria

• Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal anomalies (e.g. Turner syndrome)
• women who had had menarche at less than 3 years of age, Day 3 FSH > 15, or who were older than 46
• women with inadequate clinical/biochemical records
• and women who had had ovarian cysts or ovarian tumors in ultrasonography examination
• pregnancy women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Taipei Medical University-WanFang Hospital; 🇨🇳 Taipei, Taiwan